Premium
Delcath Systems Inc (DCTH)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to ... Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.98 | 8.36891545687 | 11.71 | 13 | 11.35 | 432617 | 12.10822512 | CS |
| 4 | 1.78 | 16.3153070577 | 10.91 | 13 | 10.2 | 569494 | 11.373965 | CS |
| 12 | 3.02 | 31.2306101344 | 9.67 | 13 | 9.47 | 447626 | 11.13378464 | CS |
| 26 | 2.47 | 24.168297456 | 10.22 | 13 | 8.485 | 448779 | 10.36746148 | CS |
| 52 | -1.29 | -9.22746781116 | 13.98 | 14.15 | 8.12 | 634947 | 10.57236206 | CS |
| 156 | 7.16 | 129.475587703 | 5.53 | 18.23 | 2.25 | 602635 | 8.65601986 | CS |
| 260 | 1.02 | 8.74035989717 | 11.67 | 18.23 | 2.25 | 378826 | 8.57058244 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
